Skip to main content
Universal Drugstore logo

Eliquis for Deep Vein Thrombosis: A Complete Treatment Guide

In This Article

What Is Eliquis and How Does It Treat Deep Vein Thrombosis?

Eliquis (apixaban) is a prescription blood thinner that belongs to a class of medications called direct oral anticoagulants (DOACs). The FDA has approved Eliquis specifically for treating deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as reducing the risk of these blood clots coming back after initial treatment.

Shop Medications

,

Deep vein thrombosis occurs when a blood clot forms in a deep vein, usually in the legs. This condition can be dangerous because pieces of the clot can break off and travel to the lungs, causing a pulmonary embolism. Eliquis works by blocking Factor Xa, a key protein in the blood clotting process. By preventing this protein from working properly, Eliquis makes it harder for new clots to form and helps prevent existing clots from getting bigger.

Unlike older blood thinners like warfarin, Eliquis does not require regular blood tests to monitor its effectiveness. This makes treatment more convenient for patients while providing reliable protection against blood clots.

How Effective Is Eliquis for DVT Treatment?

Clinical studies have shown that Eliquis is highly effective for treating deep vein thrombosis. In the major AMPLIFY trial, researchers compared Eliquis to the traditional treatment combination of enoxaparin (a blood thinner injection) followed by warfarin pills.

The results showed that Eliquis was just as effective as the conventional therapy for preventing blood clot complications. Patients taking Eliquis had similar rates of clot recurrence compared to those receiving the standard treatment. However, patients on Eliquis experienced significantly fewer major bleeding events, which is one of the main risks of blood thinner therapy.

For extended treatment beyond the initial months, the AMPLIFY-EXT study demonstrated that continuing Eliquis at a lower dose significantly reduced the risk of blood clots returning. This study compared two different Eliquis doses (2.5 mg and 5 mg twice daily) to a placebo in patients who had already completed 6 to 12 months of initial blood thinner treatment.

Both Eliquis doses were much more effective than placebo at preventing recurrent blood clots, with major bleeding rates remaining low. This research formed the foundation for using a lower dose of Eliquis for long-term prevention after the acute treatment phase.

Eliquis Dosing Schedule for Deep Vein Thrombosis

The dosing of Eliquis for DVT treatment follows a specific schedule designed to provide maximum effectiveness while minimizing bleeding risk.

Initial Treatment Phase

For the first seven days of treatment, patients typically take Eliquis 10 mg twice daily (morning and evening). This higher dose helps quickly establish effective blood-thinning levels to treat the existing clot.

Continuation Phase

After the first week, the dose is reduced to Eliquis 5 mg twice daily. Patients continue this dose for the remainder of their initial treatment period, which usually lasts 3 to 6 months depending on individual risk factors.

Extended Prevention

For patients who need long-term protection against recurrent blood clots, doctors may prescribe Eliquis 2.5 mg twice daily. This lower dose provides ongoing protection while further reducing bleeding risk for extended use.

The exact duration of treatment depends on several factors, including the cause of the original blood clot, patient risk factors, and individual bleeding risk. Some patients may need treatment for just a few months, while others require long-term anticoagulation.

Advantages of Eliquis Over Traditional Blood Thinners

Eliquis offers several important advantages compared to older blood thinner medications like warfarin, making it a preferred choice for many patients and doctors.

No Regular Blood Monitoring Required

Unlike warfarin, which requires frequent blood tests to check INR levels, Eliquis does not need routine lab monitoring. This eliminates the inconvenience of regular clinic visits and provides more predictable anticoagulation effects.

Fewer Drug and Food Interactions

Warfarin interacts with many medications and foods, particularly those high in vitamin K, like leafy green vegetables. Eliquis has fewer interactions, allowing patients more dietary freedom and simpler medication management.

Lower Bleeding Risk

Clinical studies consistently show that Eliquis causes fewer major bleeding events compared to warfarin-based treatment regimens. This improved safety profile is particularly important for long-term use.

Faster Onset and Offset

Eliquis begins working within hours rather than days, and its effects wear off relatively quickly if the medication needs to be stopped for surgery or other procedures. This provides more flexibility in managing treatment.

Common Side Effects of Eliquis

Like all blood thinners, Eliquis can cause side effects. Understanding what to expect helps patients use the medication safely and know when to contact their healthcare provider.

Common Side Effects

The most frequently reported side effects include easy bruising, minor bleeding (such as nosebleeds or bleeding gums), and fatigue. These effects occur because the medication reduces the blood’s ability to clot normally.

Some patients also experience digestive symptoms like nausea or stomach discomfort, particularly when starting the medication. Taking Eliquis with food may help reduce these symptoms.

Serious but Rare Side Effects

Major bleeding events, while less common than with older blood thinners, can still occur. Warning signs include unusual bleeding that won’t stop, blood in urine or stool, severe headaches, or signs of internal bleeding.

Spinal or epidural blood clots represent another rare but serious risk, particularly for patients who have spinal procedures while taking Eliquis. This risk requires careful coordination between healthcare providers.

Patients should contact their doctor immediately if they experience signs of serious bleeding or any concerning symptoms while taking Eliquis.

Who Should Not Take Eliquis for DVT?

While Eliquis is safe and effective for most patients, certain individuals should not use this medication or need special precautions.

Patients with active major bleeding cannot take Eliquis, as the medication would worsen the bleeding. Those with severe liver disease may also be unable to use Eliquis safely, as liver problems can affect how the body processes the medication.

Pregnant women should not take Eliquis, as safety data in pregnancy is limited. Women of childbearing age need to discuss contraception with their healthcare provider before starting treatment.

Patients with artificial heart valves typically cannot use Eliquis, as clinical studies have not established its safety and effectiveness in this population. These patients usually require warfarin therapy instead.

Kidney function also affects Eliquis dosing and safety. Patients with severe kidney disease may need dose adjustments or alternative treatments, depending on their specific situation.

Eliquis is not recommended for patients with a rare autoimmune disorder called triple-positive antiphospholipid syndrome (APS), as it has been linked to an increased risk of blood clots returning.

Making Eliquis Treatment More Affordable

The cost of prescription medications can be a significant concern for many patients requiring long-term blood thinner therapy. Several strategies can help make Eliquis treatment more accessible and affordable.

Patients should first check whether their insurance covers Eliquis and understand any prior authorization requirements or step therapy protocols that may apply. Insurance plans sometimes require trying less expensive alternatives first.

For those paying out of pocket or facing high copays, exploring cash pay options through reliable pharmacy sources can sometimes provide better pricing. Universal Drugstore offers a trusted path for patients seeking safe, cost-effective access to prescription medications, including Eliquis and generic apixaban.

Patient assistance programs from the medication manufacturer may also provide support for qualifying individuals. Healthcare providers and pharmacists can provide information about available programs and help with application processes.

Monitoring and Follow-Up During Eliquis Treatment

While Eliquis does not require the frequent blood monitoring needed with warfarin, patients still need regular follow-up care during treatment.

Healthcare providers typically schedule periodic appointments to assess treatment effectiveness, monitor for side effects, and evaluate the ongoing need for anticoagulation. These visits also provide opportunities to discuss any concerns or changes in health status.

Patients should keep track of any unusual bleeding, bruising, or other symptoms to discuss with their healthcare team. A bleeding diary can help identify patterns or triggers that may need attention.

Kidney function monitoring may be necessary for some patients, particularly those with existing kidney problems or other risk factors that could affect how the body processes Eliquis.

Regular communication with healthcare providers ensures that Eliquis treatment remains safe and effective throughout the course of therapy.

Living Well on Eliquis: Practical Tips for Patients

Successfully managing DVT treatment with Eliquis involves more than just taking the medication correctly. Patients can take several steps to optimize their treatment experience and outcomes.

Taking Eliquis at the same times each day helps maintain consistent blood levels of the medication. Setting phone alarms or using pill organizers can help establish a reliable routine.

Staying active within recommended limits supports circulation and overall health during recovery from DVT. Patients should follow their healthcare provider’s guidance about activity levels and gradually increase movement as appropriate.

Wearing compression stockings as recommended can help prevent post-thrombotic syndrome, a complication that can cause ongoing leg pain and swelling after DVT.

Maintaining good communication with all healthcare providers about Eliquis use is essential, especially before any procedures, surgeries, or dental work that might increase bleeding risk.

Understanding when to seek immediate medical attention empowers patients to respond appropriately to any concerning symptoms during treatment.

References

Related Conditions